Utilizing Stem Cell Therapies to Treat Diabetes

One of the leading embryonic stem cell research clinics in the world, EmCell Therapy, based in Kiev Ukraine, has dedicated itself to utilizing stem cell therapies to treat a multitude of diseases and conditions, among which is diabetes mellitus. Embryonic stem cell transplantation in the treatment of diseases like diabetes is one of the most promising branches of stem cell therapy research today.

Research into the treatment of diabetes mellitus with embryonic stem cell transplantation is the focus of Professor Alexandr Smikodub of EmCell Therapy Research Center. With nearly two decades of experience and having performed nearly 5,000 stem cell transplants to date, Professor Smikodub has developed an embryonic stem cell transplantation method for the treatment of diabetes mellitus which has proven effective in cases of both diabetes Type I and II. Professor Smikodub's unique method is protected by a multitude of patents as well as pending patents from countries such as Greece and Russia.

Benefits Of Embryonic Stem Cell Transplantation for the Treatment of Diabetes Mellitus
According to documented research performed by EmCell Therapy, major effects of embryonic stem cells transplantation in patients with diabetes mellitus include:

  • A decrease of glycemia in patients with insulin-dependent diabetes mellitus
  • Early and noticeable improvement of the general condition
  • Resurgence of immunity
  • Improved constitution of hematopoiesis
  • Reduction of lesions and dystrophic disorders

Research has been performed on Type I and Type II diabetes mellitus, including moderate and severe forms of the diseases. Professor Smikodub's embryonic stem cell transplantation-based method is most effective for individuals who have recently been diagnosed with insulin-dependent diabetes mellitus as well as those  suffering from Grade 1 and Grade 2 chronic renal failure and diabetic glomerulosclerosis, as well as diabetes mellitus associated with complications such as infections and decrease in immune activity.

Embryonic stem cell transplantation decreases the amount of glycemia in patients suffering from insulin-dependent diabetes mellitus and provides an overall improvement of physiological conditions, immune responses and other side effects associated with diabetes mellitus.

EmCell Therapy Clinic
Located in Kiev, Ukraine, the EmCell clinic offers treatments for additional conditions such as multiple sclerosis, Duchene's Muscular Dystrophy, blood diseases, Parkinson's disease, chronic diseases, as well as antiaging therapies. Embryonic stem cell transplants are a study of research  currently being conducted throughout the world, but few offer the innovative creativity and technology displayed by EmCell Therapy clinic staff.

Founded in 1994, researchers and staff at EmCell Therapy, one of Europe's leading cell therapy clinics, has performed more than 5,000 transplantations of embryonic stem cells in individuals from around the world and has proven to be beneficial and effective in improving quality of life in thousands of patients suffering from incurable disease processes.

Professor Alexandr Smikodub, M.D., PhD is the inventor of the embryonic stem cell transplantation treatment of diabetes mellitus method of treatment with embryonic stem cells and is also the founder of the EmCell Therapy Clinic of the National Medical University as well as EmCell clinic based in Kiev, Ukraine.

Please Click Here to request more information about Stem Cell Therpay.